Research funded by the British Heart Foundation unveils advanced scans that can detect hypertrophic cardiomyopathy before symptoms appear. These cutting-edge imaging techniques allow doctors to identify the condition's early signs, providing a valuable opportunity for timely interventions and opening doors to novel gene therapies and drug treatments.